Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 127

1.

CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.

Vennin C, Mélénec P, Rouet R, Nobis M, Cazet AS, Murphy KJ, Herrmann D, Reed DA, Lucas MC, Warren SC, Elgundi Z, Pinese M, Kalna G, Roden D, Samuel M, Zaratzian A, Grey ST, Da Silva A, Leung W; Australian Pancreatic Genome Initiative (APGI), Mathivanan S, Wang Y, Braithwaite AW, Christ D, Benda A, Parkin A, Phillips PA, Whitelock JM, Gill AJ, Sansom OJ, Croucher DR, Parker BL, Pajic M, Morton JP, Cox TR, Timpson P.

Nat Commun. 2019 Aug 12;10(1):3637. doi: 10.1038/s41467-019-10968-6.

2.

Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis.

Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Koerkamp BG.

J Natl Cancer Inst. 2019 May 14. pii: djz073. doi: 10.1093/jnci/djz073. [Epub ahead of print]

PMID:
31086963
3.

MiRNA-3653 Is a Potential Tissue Biomarker for Increased Metastatic Risk in Pancreatic Neuroendocrine Tumours.

Gill P, Kim E, Chua TC, Clifton-Bligh RJ, Nahm CB, Mittal A, Gill AJ, Samra JS.

Endocr Pathol. 2019 Jun;30(2):128-133. doi: 10.1007/s12022-019-9570-y.

PMID:
30767148
4.

Management of post-pancreatectomy haemorrhage using resuscitative endovascular balloon occlusion of the aorta.

Singh G, Nahm CB, Jamieson NB, Chua TC, Wong S, Thoo C, Mittal A, Gill AJ, Samra JS.

Langenbecks Arch Surg. 2019 Mar;404(2):253-255. doi: 10.1007/s00423-019-01759-0. Epub 2019 Feb 13.

PMID:
30758668
5.

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer.

Dreyer SB, Pinese M, Jamieson NB, Scarlett CJ, Colvin EK, Pajic M, Johns AL, Humphris JL, Wu J, Cowley MJ, Chou A, Nagrial AM, Chantrill L, Chin VT, Jones MD, Moran-Jones K, Carter CR, Dickson EJ, Samra JS, Merrett ND, Gill AJ, Kench JG, Duthie F, Miller DK, Cooke S, Aust D, Knösel T, Rümmele P, Grützmann R, Pilarsky C, Nguyen NQ, Musgrove EA, Bailey PJ, McKay CJ, Biankin AV, Chang DK; Australian Pancreatic Cancer Genome Initiative; Glasgow Precision Oncology Laboratory.

Ann Surg. 2018 Nov 30. doi: 10.1097/SLA.0000000000003143. [Epub ahead of print]

PMID:
30570546
6.

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.

Parkin A, Man J, Chou A, Nagrial AM, Samra J, Gill AJ, Timpson P, Pajic M.

Diseases. 2018 Nov 13;6(4). pii: E103. doi: 10.3390/diseases6040103. Review.

7.

Density and enhancement of the pancreatic tail on computer tomography predicts acinar score and pancreatic fistula after pancreatoduodenectomy.

Nahm CB, Lui I, Naidoo CS, Roseverne L, Alzaabi S, Maher R, Mann G, Blome S, Gill AJ, Samra JS, Mittal A.

HPB (Oxford). 2019 May;21(5):604-611. doi: 10.1016/j.hpb.2018.09.014. Epub 2018 Oct 28.

PMID:
30377050
8.

Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.

Nahm CB, Turchini J, Jamieson N, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A.

Eur J Surg Oncol. 2019 Feb;45(2):218-224. doi: 10.1016/j.ejso.2018.10.050. Epub 2018 Oct 11.

PMID:
30348604
9.

Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus.

Maharaj AD, Ioannou L, Croagh D, Zalcberg J, Neale RE, Goldstein D, Merrett N, Kench JG, White K, Pilgrim CHC, Chantrill L, Cosman P, Kneebone A, Lipton L, Nikfarjam M, Philip J, Sandroussi C, Tagkalidis P, Chye R, Haghighi KS, Samra J, Evans SM.

HPB (Oxford). 2019 Apr;21(4):444-455. doi: 10.1016/j.hpb.2018.08.016. Epub 2018 Oct 11.

PMID:
30316625
10.

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors.

Chou A, Itchins M, de Reuver PR, Arena J, Clarkson A, Sheen A, Sioson L, Cheung V, Perren A, Nahm C, Mittal A, Samra JS, Pajic M, Gill AJ.

Hum Pathol. 2018 Dec;82:249-257. doi: 10.1016/j.humpath.2018.07.032. Epub 2018 Aug 3.

11.

Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association.

Gild ML, Tsang V, Samra J, Clifton-Bligh RJ, Tacon L, Gill AJ.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3119-3123. doi: 10.1210/jc.2018-01074.

PMID:
30032256
12.

Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity.

Brown KM, Xue A, Julovi SM, Gill AJ, Pavlakis N, Samra JS, Smith RC, Hugh TJ.

J Surg Res. 2018 Jul;227:158-167. doi: 10.1016/j.jss.2018.02.018. Epub 2018 Mar 15.

PMID:
29804848
13.

Postoperative pancreatic fistula: a review of traditional and emerging concepts.

Nahm CB, Connor SJ, Samra JS, Mittal A.

Clin Exp Gastroenterol. 2018 Mar 15;11:105-118. doi: 10.2147/CEG.S120217. eCollection 2018. Review.

14.

Understanding the Pathophysiology of Psychological Distress and Pancreatic Cancer: A Systematic Review.

Bettison TM, Nahm CB, Gill AJ, Mittal A, Malhi GS, Samra JS.

Pancreas. 2018 Apr;47(4):376-381. doi: 10.1097/MPA.0000000000001016. Review.

PMID:
29521940
15.

BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma.

Chou A, Kim Y, Samra JS, Pajic M, Gill AJ.

Pathology. 2018 Apr;50(3):345-348. doi: 10.1016/j.pathol.2017.09.027. Epub 2018 Mar 3. No abstract available.

PMID:
29506751
16.

Pancreatic hamartoma: a sheep in wolf's clothing.

Nahm CB, Najdawi F, Reagh J, Kaufman A, Mittal A, Gill AJ, Samra JS.

ANZ J Surg. 2019 Jun;89(6):E265-E267. doi: 10.1111/ans.14332. Epub 2018 Jan 8. No abstract available.

PMID:
29316168
17.

Acinar cell density at the pancreatic resection margin is associated with post-pancreatectomy pancreatitis and the development of postoperative pancreatic fistula.

Nahm CB, Brown KM, Townend PJ, Colvin E, Howell VM, Gill AJ, Connor S, Samra JS, Mittal A.

HPB (Oxford). 2018 May;20(5):432-440. doi: 10.1016/j.hpb.2017.11.003. Epub 2018 Jan 5.

PMID:
29307511
18.

Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.

Stephenson D, Nahm C, Chua T, Gill A, Mittal A, de Reuver P, Samra J.

Oncotarget. 2017 Aug 4;8(63):107223-107236. doi: 10.18632/oncotarget.19928. eCollection 2017 Dec 5.

19.

Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

Balachandran VP, Łuksza M, Zhao JN, Makarov V, Moral JA, Remark R, Herbst B, Askan G, Bhanot U, Senbabaoglu Y, Wells DK, Cary CIO, Grbovic-Huezo O, Attiyeh M, Medina B, Zhang J, Loo J, Saglimbeni J, Abu-Akeel M, Zappasodi R, Riaz N, Smoragiewicz M, Kelley ZL, Basturk O; Australian Pancreatic Cancer Genome Initiative; Garvan Institute of Medical Research; Prince of Wales Hospital; Royal North Shore Hospital; University of Glasgow; St Vincent’s Hospital; QIMR Berghofer Medical Research Institute; University of Melbourne, Centre for Cancer Research; University of Queensland, Institute for Molecular Bioscience; Bankstown Hospital; Liverpool Hospital; Royal Prince Alfred Hospital, Chris O’Brien Lifehouse; Westmead Hospital; Fremantle Hospital; St John of God Healthcare; Royal Adelaide Hospital; Flinders Medical Centre; Envoi Pathology; Princess Alexandria Hospital; Austin Hospital; Johns Hopkins Medical Institutes; ARC-Net Centre for Applied Research on Cancer, Gönen M, Levine AJ, Allen PJ, Fearon DT, Merad M, Gnjatic S, Iacobuzio-Donahue CA, Wolchok JD, DeMatteo RP, Chan TA, Greenbaum BD, Merghoub T, Leach SD.

Nature. 2017 Nov 23;551(7681):512-516. doi: 10.1038/nature24462. Epub 2017 Nov 8.

20.

Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer.

Chou A, Froio D, Nagrial AM, Parkin A, Murphy KJ, Chin VT, Wohl D, Steinmann A, Stark R, Drury A, Walters SN, Vennin C, Burgess A, Pinese M, Chantrill LA, Cowley MJ, Molloy TJ; Australian Pancreatic Cancer Genome Initiative (APGI), Waddell N, Johns A, Grimmond SM, Chang DK, Biankin AV, Sansom OJ, Morton JP, Grey ST, Cox TR, Turchini J, Samra J, Clarke SJ, Timpson P, Gill AJ, Pajic M.

Gut. 2018 Dec;67(12):2142-2155. doi: 10.1136/gutjnl-2017-315144. Epub 2017 Oct 28.

Supplemental Content

Loading ...
Support Center